期刊文献+

Skp2在人类恶性肿瘤中的研究进展 被引量:5

下载PDF
导出
摘要 Skp2是泛素连接酶复合物的底物识别序列 ,对正常细胞周期起调控作用 ,在多数恶性肿瘤中表达增高。研究发现Skp2与肿瘤的预后、恶性进程、治疗均有密切关系。现就Skp2与恶性肿瘤的关系作一综述。
出处 《国外医学(肿瘤学分册)》 2004年第1期7-10,共4页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献29

  • 1Ganoth D, Bornstein G, Ko TK, et al. The cell-cycle regulatory protein CKs1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Bid, 2001,3(3) :321-324.
  • 2Yokoi S, Yasui K, Saito Ohara F, et al. A novel target gene,SKP2, within the 5p13 amplicon that is frequently detected in smaall cell lung cancers. Am J Pathol, 2002,161 ( 1 ) : 207-216.
  • 3Schulman BA, Carrano AC, Jeffrey PD, et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 ctmaplex. Nature, 2000, 408(6810) :381-386.
  • 4Nakayarna K, Nagahama H, Minamishima YA, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kipl ),polyploidy and centrosome overduplication. EMBO J, 2000,19(9) :2069-2081.
  • 5Ezoe S, Matsumura I, Nakata S, et al. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21 (WAF1) and p27 (Kipl) proteins.Blood, 2002,100 ( 10 ) : 3512-3520.
  • 6Carrano AC, Pagano M. Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol, 2001,153 (7):1381-1390.
  • 7Malek NP, Sundberg H, McGrew S, et al. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kipl in G1 and S phase. Nature, 2001,413(6853) :323-327.
  • 8Sitry D, Seeliger MA, Ko TK, et al. Three different binding sites of Cksl are required for p27-ubiquitin ligation. J Biol Chem, 2002,277(44) :42233-42240.
  • 9Bornstein G, Bloom J, Sitry Shevah D, et al. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cipl in S phase. J Biol Chem, 2003,278(28):25752-25757.
  • 10Yeh KH, Kondo T, Zheng J, et al. The F-box protein Skp2 binds to the pbosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E. Biochem Biophys Res Commun, 2001,281(4) :884-890.

同被引文献62

  • 1Brown DC, Garter KC. Ki-67 Protein: the immaculate decepion[J]? Histopathology , 2002, 40 : 2-11.
  • 2Duchrow M, Sehluter C, Wohlenberg C, et al. Molecular Characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67[J]. Cell Prolif ,1996, 29(1) :1-12.
  • 3Scholzen T, Gerdes J. The Ki-67 protein:From the known and unknown[J]. J Cell Physiol ,2000,182(3) :311-22.
  • 4K Iino, H Sasano, N Yabuki, et al . DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas [J]. Pathology ,1997;10(9):901-907.
  • 5Terzolo M, Boccuzzi A, Bovio S, et al . Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortieal tumors[J]. Urology , 2001,57(1) : 176-182.
  • 6Wachenfeld C,Beuschlein F, Zwermann O, et al . Discerning malignancy in adrenocortical tumors: are molecular markers useful[J]? Eur J Endocrinol ,2001, 145(3) :335-341.
  • 7Kuo MY, Hsu HY, Kok SH, et al . Prognostic role of p27K IP expression in oral squamous cell careinom a in Taiwan[J]. Oral Oncol ,2002,38(2):172.
  • 8H Nakazumi, H Sasano,K Iino, et al . Expression of cell cycle inhibitor p27 and Ki 67 in human adrenocortical neoplasms [J]. Mod Pathol ,1998,11(12) :1165-1170.
  • 9Nakayama K ,Ishida N ,Shirane M, et al . Mice lacking p27 (Kipl) display increased body size,multiple organ hyperplasia,retinal dysplasia, and pituitary tumors[J]. Cell , 1996,85 (5) :707-772.
  • 10YAMASAKI L,PAGANO M.Cell cycle,proteolysis and cancer[J].Curr Opin Cell Biol,2004,16(6):623-628.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部